Structural insights into activation mechanisms on NADase of the bacterial DSR2 anti-phage defense system

A cryptic site in class 5 epitope of SARS-CoV-2 RBD maintains highly conservation across natural isolates

Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants

Risedronate-functionalized manganese-hydroxyapatite amorphous particles: A potent adjuvant for subunit vaccines and cancer immunotherapy

Rational design of a cross-type HPV vaccine through immunodominance shift guided by a cross-neutralizing antibody

Empirical validation of ProteinMPNN's efficiency in enhancing protein fitness

Micronanoparticled risedronate exhibits potent vaccine adjuvant effects

In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives

Molecular engineering tools for the development of vaccines against infectious diseases: current status and future directions

Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection

Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

Structure and proposed DNA delivery mechanism of a marine roseophage

Precision and correlation of ED50 and endpoint titer method in measuring HPV vaccine immunogenicity

Design of Multicomponent Peptide Fibrils with Ordered and Programmable Compositional Patterns

Design of Multicomponent Peptide Fibrils with Ordered and Programmable Compositional Patterns

Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for <i>Escherichia coli</i>-based vaccine design

A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunity

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine

Current progress in the development of prophylactic and therapeutic vaccines

Omics-guided bacterial engineering of Escherichia coli ER2566 for recombinant protein expression

Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70

A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26

Genetic engineering of baculovirus-insect cell system to improve protein production

A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode

Structural basis for the synergistic neutralization of coxsackievirus B1 by a triple-antibody cocktail

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses

Endodomain truncation of the HIV-1 envelope protein improves the packaging efficiency of pseudoviruses

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2

Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion

Baculovirus Display of Varicella-Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron

A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice

Structures of pseudorabies virus capsids

Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209

Pre-existing maternal IgG antibodies as a protective factor against congenital cytomegalovirus infection: A mother-child prospective cohort study

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells

Nanospheres from coordination polymers of Ag+ with a highly hydrophilic thiol ligand formed in situ from dynamic covalent binding and a hydrophobic thiol

Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters

In situ analysis of biomolecular interactions on nano/microparticles in formulations

Structural Basis for the Shared Neutralization Mechanism of Three Classes of Human Papillomavirus Type 58 Antibodies with Disparate Modes of Binding

Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating

The Dual Function of KDM5C in Both Gene Transcriptional Activation and Repression Promotes Breast Cancer Cell Growth and Tumorigenesis

Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes

Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids

Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs

Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans

Structure guided maturation of a novel humanized anti-HBV antibody and its preclinical development

Functional epitopes on hepatitis E virions and recombinant capsids are highly conformation-dependent

Genome re-sequencing and reannotation of the Escherichia coli ER2566 strain and transcriptome sequencing under overexpression conditions

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles

Recent Progress on the Versatility of Virus-Like Particles

Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice

Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates

Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods

Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation

Viral neutralization by antibody-imposed physical disruption

Simultaneous in situ visualization and quantitation of dual antigens adsorbed on adjuvants using high content analysis

Altered antigenicity and immunogenicity of human papillomavirus virus-like particles in the presence of thimerosal

Construction of a bacterial surface display system based on outer membrane protein F

Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A

Characterization of native-like HIV-1 gp140 glycoprotein expressed in insect cells

Impact of naturally occurring variation in the human papillomavirus 52 capsid proteins on recognition by type-specific neutralising antibodies

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection

Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity

T=4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display

Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine

Impact of Naturally Occurring Variation in the Human Papillomavirus 58 Capsid Proteins on Recognition by Type-Specific Neutralizing Antibodies

Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro

Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10

Identification of Strategic Residues at the Interface of Antigen-Antibody Interactions by In Silico Mutagenesis

Characterization of capsid protein (p495) of hepatitis E virus expressed ID in Escherichia coli and assembling into particles in vitro

Expression, Purification and Characterization of Hiv-1 Capsid Precursor Protein p41

Characterization and epitope mapping of a panel of monoclonal antibodies against HIV-1 matrix protein

Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody

Characterization of an Escherichia coil-derived human papillomavirus type 16 and 18 bivalent vaccine

Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity

A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus

Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli

Real-time stability of a hepatitis E vaccine (Hecolin (R)) demonstrated with potency assays and multifaceted physiochemical methods

Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies

A shared N-terminal hydrophobic tail for the formation of nanoparticulates

Quantitative and epitope-specific antigenicity analysis of the human papillomavirus 6 capsid protein in aqueous solution or when adsorbed on particulate adjuvants

The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction

Production of Influenza Virus HA1 Harboring Native-Like Epitopes by Pichia pastoris

Functional assessment and structural basis of antibody binding to human papillomavirus capsid

A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5

Prophylaxis against hepatitis E: at risk populations and human vaccines

Virus-mimetic nanovesicles as a versatile antigen-delivery system

Molecular insights into the inhibition of HIV-1 infection using a CD4 domain-1-specific monoclonal antibody

Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial

Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin (R)

Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes

Improved characteristics and protective efficacy in an animal model of E-coli-derived recombinant double-layered rotavirus virus-like particles

Toward the development of monoclonal antibody-based assays to probe virion-like epitopes in hepatitis B vaccine antigen

Virus-like particle-based human vaccines: Quality assessment based on structural and functional properties

Structure of a Novel Shoulder-to-Shoulder p24 Dimer in Complex with the Broad-Spectrum Antibody A10F9 and Its Implication in Capsid Assembly

Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts

Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy

Development of the Hepatitis E Vaccine: From Bench to Field

Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity

The enhancement of RNAi against HIV in vitro and in vivo using H-2K(k) protein as a sorting method

Structural and biophysical characterization of Mycobacterium tuberculosis dodecin Rv1498A

Structural basis for the neutralization and genotype specificity of hepatitis E virus

Homology model and potential virus-capsid binding site of a putative HEV receptor Grp78

A Comparative Proteomic Analysis Reveals a New Bi-Lobe Protein Required for Bi-Lobe Duplication and Cell Division in Trypanosoma brucei

Dimerization of Hepatitis E Virus Capsid Protein E2s Domain Is Essential for Virus-Host Interaction

Expression and purification of soluble HIV-1 envelope glycoprotein gp160 mutant from Saccharomyces cerevisiae

Cytosporone B is an agonist for nuclear orphan receptor Nur77

Prediction of a common neutralizing epitope of H5N1 avian influenza virus by in silico molecular docking

Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity

Variants of green fluorescent protein GFPxm

Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein

A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates

Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid

Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus

Selection of a peptide mimicking neutralization epitope of hepatitis E virus with phage peptide display technology

Alkaline unfolding and salt-induced folding of yeast alcohol dehydrogenase under high pH conditions